Skip to main content

Advertisement

Table 3 UE-FM subscales outcome measures at end of treatment and at follow-up

From: Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy

Within-group analysis   Between-group analysis
Mean (SD) - Median 95 % confidence interval for the mean (lower and upper bound)   p-values
  End of treatment Change from p-values Follow-up Change from p-values Change from Change from
  T1 baseline to T1   T2 baseline to T2   baseline to T1 baseline to T2
Total UE-FM         
EG 38.33 (17.30) – 39 6.00 (6.31) – 4 .008 46.22 (14.96) – 52 13.89 (9.88) – 10 .004   
  [25.04–51.63] [1.15–10.85]   [34.72–57.73] [6.29–21.48]    
        .715 .037
CG 43.22 (12.62) – 44 6.33 (4.50) – 7 .008 41.78 (12.47) – 40 4.89 (4.31) – 5 .016   
  [33.52–52.92] [2.87–9.79]   [32.19–51.36] [1.57–8.20]    
UE-FM-Proximal         
EG 21.00 (8.90) – 18 4.00 (3.57) – 4 .016 24.11 (7.67) – 27 7.11 (4.65) – 8 .004   
  [10.25–25.75] [-0.38–7.63]   [21.38–32.63] [-1.01–6.12]    
        .619 .420
CG 24.22 (6.50) – 24 5.33 (4.80) – 4 .016 24.33 (7.23) – 24 5.44 (5.30) – 4 .016   
  [18.13–29.88] [-0.75–8.75]   [17.62–30.38] [4.63–11.38]    
UE-FM-Wrist         
EG 7.22 (3.31) – 9 1.44 (2.07) – 1 .063 8.33 (2.00) – 9 2.56 (2.35) – 1 .016   
  [6.89–11.13] [0.0–2.0]   [7.63–10.38] [-1.13–3.13]    
        .375 .350
CG 5.44 (2.92) – 5 0.67 (1.94) – 0 .500 6.22 (2.77) – 5 1.44 (2.40) – 1 .156   
  [3.38–6.63] [-0.63–0.63]   [2.88–7.13] [-0.75–2.75]    
UE-FM-Hand         
EG 8.44 (5.36) – 9 1.00 (2.29) – 0 .250 9.33 (4.64) – 10 1.89 (4.01) – 1 .250   
  [5.13–12.88] [-0.50–0.50]   [7.38–12.63] [-0.25–2.25]    
        .116 .055
CG 10.22 (2.63) – 11 -1.22 (3.46) – 0 .500 9.89 (3.79) – 12 -1.56 (3.94) – 0 .313   
  [8.50–13.50] [-0.63–0.63]   [9.50–14.50] [-1.37–1.37]    
UE-FM-Coordination         
EG 2.89 (1.83) – 4 0.33 (1.00) – 0 1.000 3.00 (1.94) – 4 0.44 (1.01) – 0 .500   
  [2.75–5.25] [0.00–0.00]   [2.63–5.38] [-1.25–1.25]    
        .294 .587
CG 3.22 (1.48) – 3 0.44 (0.53) – 0 .125 3.44 (1.81) – 3 0.67 (1.00) – 0 .125   
  [2.38–3.63] [-0.50–0.50]   [1.88–4.13] [-0.50–0.50]    
  1. Bold values indicate significant values (p<.05), p-values for within-group analysis were obtained with Wilcoxon signed-rank test, p-values for between-group analysis were obtained with Wilcoxon rank-sum test